Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study

Cancer
Leida M LamersEORTC 26981/22981 NCI-C CE3 Intergroup Study

Abstract

The study aimed to compare the cost-effectiveness of concomitant and adjuvant temozolomide (TMZ) for the treatment of newly diagnosed glioblastoma multiforme versus initial radiotherapy alone from a public health care perspective. The economic evaluation was performed alongside a randomized, multicenter, phase 3 trial. The primary endpoint of the trial was overall survival. Costs included all direct medical costs. Economic data were collected prospectively for a subgroup of 219 patients (38%). Unit costs for drugs, procedures, laboratory and imaging, radiotherapy, and hospital costs per day were collected from the official national reimbursement lists based on 2004. For the cost-effectiveness analysis, survival was expressed as 2.5 years restricted mean estimates. The incremental cost-effectiveness ratio (ICER) was constructed. Confidence intervals for the ICER were calculated using the Fieller method and bootstrapping. The difference in 2.5 years restricted mean survival between the treatment arms was 0.25 life-years and the ICER was euro37,361 per life-year gained with a 95% confidence interval (CI) ranging from euro19,544 to euro123,616. The area between the survival curves of the treatment arms suggests an increase of the o...Continue Reading

References

Sep 1, 1994·Health Economics·B A van HoutF F Rutten
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Jan 15, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tammy O Tengs
Feb 25, 2005·Health Economics·Jan B Oostenbrink, Maiwenn J Al
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 4, 2005·Current Opinion in Oncology·Carin A Uyl-de Groot, Giuseppe Giaccone
Dec 3, 2005·The Lancet Oncology·Martin J B TaphoornUNKNOWN National Cancer Institute of Canada Clinical Trials Group

❮ Previous
Next ❯

Citations

Apr 24, 2012·Neurologia Medico-chirurgica·Naoyuki HattoriYoichi Katayama
Oct 23, 2012·Expert Review of Neurotherapeutics·Pasquale De BonisAnnunziato Mangiola
Feb 27, 2009·Expert Opinion on Investigational Drugs·Sith Sathornsumetee, David A Reardon
Jun 3, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·C NiederR Jalali
Nov 8, 2008·Annals of the New York Academy of Sciences·Sith Sathornsumetee, Jeremy N Rich
Oct 11, 2011·Hematology/oncology and Stem Cell Therapy·Ahmed SalemAbdelatif Almousa
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruno Kovic, Feng Xie
Dec 4, 2014·Journal of Oncology Practice·Jeffrey J RaizerJune M McKoy
Mar 24, 2020·The Cochrane Database of Systematic Reviews·Catherine HannaRobin Grant
Feb 13, 2009·Journal of Neuro-oncology·Antonio SilvaniAndrea Salmaggi
Jun 25, 2020·Journal of Neuro-oncology·Pavan P ShahDebraj Mukherjee
Jun 17, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Carin A Uyl-de GrootMartin van der Bent
Oct 19, 2010·Journal of Neuro-oncology·Christian EweltMichael Sabel
Jan 16, 2021·JCO Global Oncology·Nidhi GuptaPankaj Bahuguna
Nov 2, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Martin ConnockXavier Armoiry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Pharmacoeconomics & Outcomes Research
Carin A Uyl-de GrootMartin van der Bent
The Lancet Oncology
Martin J B TaphoornNational Cancer Institute of Canada Clinical Trials Group
The New England Journal of Medicine
R StuppNational Cancer Institute of Canada Clinical Trials Group
© 2021 Meta ULC. All rights reserved